ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,303.27
0.12%
US Tech 100
18,062.00
-0.10%
다우존스 지수
40,003.59
0.34%
Bitcoin
66,942.75
-0.21%
Registration Strip Icon for alerts 실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. La Jolla Pharmaceutical Company (LJPC)

  7. La Jolla Pharmaceutical Company (LJPC) 뉴스

LJPC

La Jolla Pharmaceutical (LJPC)

La Jolla Pharmaceutical Company
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:LJPC
일자시간출처헤드라인심볼기업
2023/02/1500:07Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:LJPCLa Jolla Pharmaceutical Company
2022/09/0121:39Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(g) (15-12g)NASDAQ:LJPCLa Jolla Pharmaceutical Company
2022/08/3001:31Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:LJPCLa Jolla Pharmaceutical Company
2022/08/3001:10Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:LJPCLa Jolla Pharmaceutical Company
2022/08/2406:01Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:LJPCLa Jolla Pharmaceutical Company
2022/08/2406:01Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:LJPCLa Jolla Pharmaceutical Company
2022/08/2406:01Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:LJPCLa Jolla Pharmaceutical Company
2022/08/2406:01Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:LJPCLa Jolla Pharmaceutical Company
2022/08/2406:01Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:LJPCLa Jolla Pharmaceutical Company
2022/08/2222:32Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)NASDAQ:LJPCLa Jolla Pharmaceutical Company
2022/08/2222:22Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:LJPCLa Jolla Pharmaceutical Company
2022/08/2222:20Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:LJPCLa Jolla Pharmaceutical Company
2022/08/2222:09Edgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:LJPCLa Jolla Pharmaceutical Company
2022/08/2221:55Business WireInnoviva Completes Acquisition of La Jolla PharmaceuticalNASDAQ:LJPCLa Jolla Pharmaceutical Company
2022/08/1521:14Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:LJPCLa Jolla Pharmaceutical Company
2022/08/1521:04Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:LJPCLa Jolla Pharmaceutical Company
2022/07/2521:40Edgar (US Regulatory)Statement of Ownership: Solicitation (sc 14d9)NASDAQ:LJPCLa Jolla Pharmaceutical Company
2022/07/2521:35Edgar (US Regulatory)Tender Offer Statement by Third Party (sc To-t)NASDAQ:LJPCLa Jolla Pharmaceutical Company
2022/07/1219:10Edgar (US Regulatory)Written Communication by the Subject Company Relating to a Third Party Tender Offer (sc14d9c)NASDAQ:LJPCLa Jolla Pharmaceutical Company
2022/07/1219:01Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:LJPCLa Jolla Pharmaceutical Company
2022/07/1204:47Edgar (US Regulatory)Written Communication Relating to an Issuer or Third Party (sc To-c)NASDAQ:LJPCLa Jolla Pharmaceutical Company
2022/07/1120:36Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:LJPCLa Jolla Pharmaceutical Company
2022/07/1120:32Business WireInnoviva to Acquire La Jolla Pharmaceutical CompanyNASDAQ:LJPCLa Jolla Pharmaceutical Company
2022/07/0606:52Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:LJPCLa Jolla Pharmaceutical Company
2022/05/1806:08Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:LJPCLa Jolla Pharmaceutical Company
2022/05/1705:18Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:LJPCLa Jolla Pharmaceutical Company
2022/05/1705:15Business WireLa Jolla Pharmaceutical Company Announces Financial Results for the Three Months Ended March 31, 2022 and Highlights Corporate ProgressNASDAQ:LJPCLa Jolla Pharmaceutical Company
2022/04/1907:33Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:LJPCLa Jolla Pharmaceutical Company
2022/04/1907:31Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:LJPCLa Jolla Pharmaceutical Company
2022/04/0506:40Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:LJPCLa Jolla Pharmaceutical Company
 검색 관련기사 보기:NASDAQ:LJPC

최근 히스토리

BIT
UC172P
Unicredit Bank
LSE
SL79
Barclays 25
TSX
CALL.B
Evolve US Banks Enchance...
BIT
P34324
Bnp Paribas Issuance
NASDAQ
ATLC
Atlanticus
GATE
LEVUSDT
Lever Token
EU
1711T
1711T
AQSE
CNG.GB
China Nonferrous Gold
ASX
IEQ
International Equities
LSE
RFX
Ramsdens
NASDAQ
TACXC
A Consulting
KUCN
WOMBATUSDT
Wombat
EU
C10
AMUNDI ETF GOVT BOND EUR...
LSE
FMN
COIN
HEARTEUR
Humans.ai
BIT
UC3C77
Unicredit Bank
Delayed Upgrade Clock
ADVFN Logo

대한민국
회사 소개
사업
Popular
앱 받기

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유